Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Int J Mycobacteriol ; 11(4): 457-459, 2022.
Article in English | MEDLINE | ID: mdl-36510935

ABSTRACT

Leprosy and human immunodeficiency virus (HIV) often mimic clinical features of connective tissue disease (CTD). They can present such as lupus, rheumatoid arthritis, scleroderma, or overlap syndromes and it sometimes creates confusion about the diagnosis. Serology may not be enough to differentiate the two and effective tissue biopsies are often the answer. We report the case of a 38-year-old female, who presented clinically with features of multisystem involvement suspected to be CTD, but was found to have dual infection: HIV and borderline tuberculoid leprosy.


Subject(s)
HIV Infections , Leprosy, Borderline , Leprosy , Female , Humans , Adult , HIV , Leprosy/complications , Leprosy/diagnosis , Biopsy , HIV Infections/complications , HIV Infections/diagnosis
2.
Ann Rheum Dis ; 81(5): e87, 2022 05.
Article in English | MEDLINE | ID: mdl-32467246
3.
J Clin Rheumatol ; 27(3): 114-119, 2021 Apr 01.
Article in English | MEDLINE | ID: mdl-31804256

ABSTRACT

OBJECTIVES: We explored causes of in-hospital mortality in patients with inflammatory myositis at a tertiary care center in Northern India. METHODS: Records of adults and children diagnosed with dermatomyositis (DM), polymyositis, or anti-synthetase syndrome (ASSD) who died between 2000 and 2018 were reviewed, and causes of death were determined. RESULTS: Of the 38 patients, 20 had DM (including 2 clinically amyopathic DM), 4 juvenile DM, 12 polymyositis, whereas 2 had ASSD. Median age at death was 42.0 (interquartile range, 32.8-52.5) years. Median disease duration at death was 18.5 (interquartile range, 2.0-23.5) months. Twenty-four (63.2%) had infection as the primary cause of death. Other causes of death included pharyngeal muscle weakness and aspiration (n = 6), myocarditis (n = 2), respiratory failure (n = 2), cerebral bleed (n = 2), and pulmonary embolism (n = 1). One patient succumbed to rapidly progressive interstitial lung disease, whereas another patient with ASSD died following respiratory distress after rituximab infusion. In post hoc analysis, although thrombocytopenia appeared to be a risk factor for early mortality (odds ratio, 13.3; 95% confidence interval, 1.4-123.8; p = 0.01), this was not supported in the multivariate analysis. CONCLUSIONS: Infections are the most common cause of in-hospital mortality in myositis patients.


Subject(s)
Dermatomyositis , Myositis , Polymyositis , Adult , Child , Dermatomyositis/complications , Dermatomyositis/diagnosis , Hospital Mortality , Humans , Myositis/diagnosis , Polymyositis/diagnosis , Retrospective Studies
SELECTION OF CITATIONS
SEARCH DETAIL
...